Suad Aljohani

777 total citations
19 papers, 500 citations indexed

About

Suad Aljohani is a scholar working on Oncology, Orthopedics and Sports Medicine and Rheumatology. According to data from OpenAlex, Suad Aljohani has authored 19 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Orthopedics and Sports Medicine and 6 papers in Rheumatology. Recurrent topics in Suad Aljohani's work include Bone health and treatments (11 papers), Bone and Joint Diseases (8 papers) and Osteomyelitis and Bone Disorders Research (5 papers). Suad Aljohani is often cited by papers focused on Bone health and treatments (11 papers), Bone and Joint Diseases (8 papers) and Osteomyelitis and Bone Disorders Research (5 papers). Suad Aljohani collaborates with scholars based in Saudi Arabia, Germany and United Kingdom. Suad Aljohani's co-authors include Sven Otto, Michael Ehrenfeld, Riham Fliefel, Jan Kühnisch, Matthias Troeltzsch, Maddalena Manfredi, Francesco D’Aiuto, Anna Musciotto, Stefano Fedele and Paolo Vescovi and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Medicine and Journal of Clinical Medicine.

In The Last Decade

Suad Aljohani

16 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suad Aljohani Saudi Arabia 9 415 362 115 46 45 19 500
Heba Hussein Egypt 6 199 0.5× 154 0.4× 49 0.4× 29 0.6× 33 0.7× 25 303
L Béraneck France 5 78 0.2× 101 0.3× 323 2.8× 2 0.0× 18 0.4× 18 383
Donncha O’Gradaigh United Kingdom 6 48 0.1× 104 0.3× 52 0.5× 4 0.1× 8 0.2× 11 207
Sarek Shen United States 10 121 0.3× 14 0.0× 10 0.1× 20 0.4× 42 0.9× 26 328
Bente Langdahl Denmark 8 84 0.2× 134 0.4× 45 0.4× 2 0.0× 8 0.2× 22 259
Ana Capote Spain 8 122 0.3× 4 0.0× 50 0.4× 39 0.8× 49 1.1× 12 298
Carla Isabelly Rodrigues‐Fernandes Brazil 10 83 0.2× 3 0.0× 32 0.3× 24 0.5× 42 0.9× 38 244
Agnès Bouchaud-Chabot France 5 57 0.1× 111 0.3× 305 2.7× 5 0.1× 9 407
Juan José Jaller Colombia 6 31 0.1× 156 0.4× 39 0.3× 4 0.1× 2 0.0× 11 236
Dai Shimizu Japan 10 41 0.1× 8 0.0× 29 0.3× 6 0.1× 55 1.2× 32 278

Countries citing papers authored by Suad Aljohani

Since Specialization
Citations

This map shows the geographic impact of Suad Aljohani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suad Aljohani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suad Aljohani more than expected).

Fields of papers citing papers by Suad Aljohani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suad Aljohani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suad Aljohani. The network helps show where Suad Aljohani may publish in the future.

Co-authorship network of co-authors of Suad Aljohani

This figure shows the co-authorship network connecting the top 25 collaborators of Suad Aljohani. A scholar is included among the top collaborators of Suad Aljohani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suad Aljohani. Suad Aljohani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Poxleitner, Philipp, Suad Aljohani, Bente Brokstad Herlofson, et al.. (2025). Evaluation of a context-aware chatbot using retrieval-augmented generation for answering clinical questions on medication-related osteonecrosis of the jaw. Journal of Cranio-Maxillofacial Surgery. 53(4). 355–360. 8 indexed citations
3.
Farag, Arwa M., et al.. (2024). Employment Opportunities, Latency, and Satisfaction among KAUFD Graduates. The Open Dentistry Journal. 18(1).
4.
Aljohani, Suad, et al.. (2023). Oral manifestations in hospital-admitted COVID-19 patients: a case control study. SHILAP Revista de lepidopterología. 4. 1180017–1180017. 1 indexed citations
5.
Binmadi, Nada, et al.. (2023). Perineural Invasion Is a Significant Prognostic Factor in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Diagnostics. 13(21). 3339–3339. 10 indexed citations
6.
Aljohani, Suad, et al.. (2023). Tear Cytokine Levels in Sicca Syndrome-Related Dry Eye: A Meta-Analysis. Diagnostics. 13(13). 2184–2184. 8 indexed citations
7.
Aljohani, Suad. (2023). Awareness, perceptions and attitudes toward medication-related osteonecrosis of the jaw among physicians who treat osteoporosis. Saudi Pharmaceutical Journal. 31(9). 101707–101707. 1 indexed citations
8.
Binmadi, Nada, et al.. (2023). Salivary Oxidative Stress and Antioxidant Capacity in Smokeless Tobacco (Naswar) Users. Clinical Cosmetic and Investigational Dentistry. Volume 15. 121–132. 3 indexed citations
9.
Aljohani, Suad, et al.. (2022). Fluorescence-guided surgery for osteoradionecrosis of the jaw: a retrospective study. Journal of International Medical Research. 50(6). 3629165114–3629165114. 2 indexed citations
10.
Binmadi, Nada, et al.. (2022). Oral Manifestations of COVID-19: A Cross-Sectional Study of Their Prevalence and Association with Disease Severity. Journal of Clinical Medicine. 11(15). 4461–4461. 16 indexed citations
11.
Otto, Sven, Matthias Troeltzsch, Gabriele Kaeppler, et al.. (2022). Clinical and Radiographic Outcomes of Dental Implants in Patients Treated With Antiresorptive Drugs: A Consecutive Case Series. Journal of Oral Implantology. 49(1). 39–45. 4 indexed citations
12.
Otto, Sven, Suad Aljohani, Riham Fliefel, et al.. (2021). Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ). Medicina. 57(5). 463–463. 66 indexed citations
13.
Binmadi, Nada, et al.. (2021). Oral lesions associated with smokeless tobacco users in Saudi Arabia: Single center cross-sectional study. The Saudi Dental Journal. 34(2). 114–120. 8 indexed citations
14.
Otto, Sven, Selgai Haidari, Suad Aljohani, et al.. (2020). Autofluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw (MRONJ): a retrospective single-center study. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 131(5). 519–526. 18 indexed citations
15.
Aljohani, Suad, Robert Gaudin, Matthias Tröltzsch, et al.. (2018). Osteonecrosis of the jaw in patients treated with denosumab: A multicenter case series. Journal of Cranio-Maxillofacial Surgery. 46(9). 1515–1525. 45 indexed citations
16.
Aljohani, Suad, Matthias Troeltzsch, S. Häfner, et al.. (2018). Surgical treatment of medication‐related osteonecrosis of the upper jaw: Case series. Oral Diseases. 25(2). 497–507. 39 indexed citations
17.
Aljohani, Suad, et al.. (2017). Osteomyelitis der Kieferknochen. Osteologie/Osteology. 26(4). 236–243.
18.
Aljohani, Suad, et al.. (2017). What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review. Journal of Cranio-Maxillofacial Surgery. 45(9). 1493–1502. 93 indexed citations
19.
Fedele, Stefano, Stephen Porter, Francesco D’Aiuto, et al.. (2010). Nonexposed Variant of Bisphosphonate-associated Osteonecrosis of the Jaw: A Case Series. The American Journal of Medicine. 123(11). 1060–1064. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026